DELVING INTO THE ONCOGENIC RISK OF AAV GENE THERAPY - Optimizing AAV Safety Summit

Skip to content

This event ran on: July 11-13, 2023

Thank you joining us in Boston, MA

Register Your Interest For 2024

Your Next Meeting in the Gene Therapy Series: Gene Therapy Process Development Summit

Home
About
What’s On?
- 2023 Full Event Guide
- 2023 Speakers
Partner
Take Part
- Register Interest
- Contact Us

DELVING INTO THE ONCOGENIC RISK OF AAV GENE THERAPY

Time: 1:35 pm
day: Day Two

OUR CONTACT DETAILS

Phone
UK: +44 (0)20 3141 8700
US: +1 617 455 4188

Email
info@hansonwade.com

JOIN OUR TEAM

We are always looking for ambitious people to join our team. You'll have opportunities to learn quickly, advance your career, and to meaningfully impact our customers and our business.

Click here to learn about careers.

ABOUT US

Hanson Wade specializes in scientific research across a comprehensive range of distinctive R&D areas. We deliver insight and connections to facilitate safe and effective drug development for more personalized and targeted patient populations.

EXPLORE OUR PRODUCTS

Conferences	Beacon
Searchlight	Intelligence

SEARCH

Search

ORGANIZED BY

Terms & Conditions

Privacy Policy

A Hanson Wade Group Company

HWG

© Copyright 2024 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.Ok